Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study
George Khoudari, Emad Mansoor, Benjamin Click, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 20, Iss. 5, pp. e974-e983
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 28
The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease
Christopher A Lamb, Aamir Saifuddin, Nick Powell, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1525-1542
Open Access | Times Cited: 48
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus
Daniel R. Dickstein, Collin R. Edwards, Catherine Rowan, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 6, pp. 377-405
Open Access | Times Cited: 7
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fuméry, Jérôme Filippi, Véred Abitbol, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 7, pp. 944-951
Closed Access | Times Cited: 39
Alzheimer Disease Occurs More Frequently In Patients With Inflammatory Bowel Disease
Manik Aggarwal, Motasem Alkhayyat, Mohannad Abou Saleh, et al.
Journal of Clinical Gastroenterology (2022) Vol. 57, Iss. 5, pp. 501-507
Closed Access | Times Cited: 27
Current approaches to the surgical management of Crohn’s disease in Australia and New Zealand
Sophie Zheng, Aleksandra Edmundson, David A. Clark
International Journal of Colorectal Disease (2025) Vol. 40, Iss. 1
Open Access
Operative Management of Small and Large Bowel Crohn’s Disease
Imran Khan, Stefan D. Holubar
Surgical Clinics of North America (2025) Vol. 105, Iss. 2, pp. 247-276
Closed Access
Self‐assessment with pediatric inflammatory bowel disease endoscopy scoring tools: A quality improvement pilot study
Alexandra Hudson, Ghassan Wahbeh, Dale Lee, et al.
JPGN Reports (2025)
Open Access
Epidemiology and risk of psychiatric disorders among patients with celiac disease: A population‐based national study
Motasem Alkhayyat, Thabet Qapaja, Manik Aggarwal, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 8, pp. 2165-2170
Closed Access | Times Cited: 26
Increasing Rates of Bowel Resection Surgery for Stricturing Crohn’s Disease in the Biologic Era
Kush Fansiwala, Ellen J. Spartz, Andrew R. Roney, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Epidemiology of neuroendocrine tumors of the appendix in the USA: a population-based national study (2014-2019)
Motasem Alkhayyat
Annals of Gastroenterology (2021)
Open Access | Times Cited: 23
Epidemiology of gallbladder cancer in the Unites States: a population-based study
Motasem Alkhayyat, Mohannad Abou Saleh, Thabet Qapaja, et al.
Chinese Clinical Oncology (2021) Vol. 10, Iss. 3, pp. 25-25
Open Access | Times Cited: 21
Short Bowel Syndrome in Adults
Jamie Bering, John K. DiBaise
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 6, pp. 876-883
Closed Access | Times Cited: 13
Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis
Yun Han Kwon, Benjamin E. Blass, Huaqing Wang, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 327, Iss. 1, pp. G57-G69
Closed Access | Times Cited: 2
High-throughput omics technologies in inflammatory bowel disease
Chen Xu, Jing Shao
Clinica Chimica Acta (2024) Vol. 555, pp. 117828-117828
Closed Access | Times Cited: 2
Financial toxicity among patients undergoing resectional surgery for inflammatory bowel disease in the United States
Yung Lee, Sama Anvari, Adelia Padoan, et al.
Colorectal Disease (2024) Vol. 26, Iss. 4, pp. 692-701
Closed Access | Times Cited: 2
Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis
Jun Miyoshi, Tsubasa Maeda, Katsuyoshi Matsuoka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review
Edgar Akuffo‐Addo, Theodora Udounwa, Jocelyn Chan, et al.
Journal of Racial and Ethnic Health Disparities (2022) Vol. 10, Iss. 2, pp. 942-951
Open Access | Times Cited: 10
Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study
Guillaume Le Cosquer, Romain Altwegg, Pauline Rivière, et al.
Digestive and Liver Disease (2022) Vol. 55, Iss. 6, pp. 727-734
Open Access | Times Cited: 10
Immune checkpoint inhibitor induced colitis: A nationwide population-based study
Natalie Farha, Motasem Alkhayyat, Adrian Lindsey, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 46, Iss. 1, pp. 101778-101778
Closed Access | Times Cited: 12
Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection
Sarah Rotondo‐Trivette, Beibei Wang, Christopher P. Gayer, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 6, pp. 792-804
Open Access | Times Cited: 11
Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
Rogério Serafim Parra, Sandro da Costa Ferreira, Vanessa Foresto Machado, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2672-2672
Open Access | Times Cited: 4
Temporal trends in surgery for Crohn’s disease: a ten-year single-center retrospective study
Wei Liu, Xiaolong Ge, Zhaoqi Shi, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Priscila Santiago, Nayantara Coelho–Prabhu, Ryan J. Lennon, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 147-154
Closed Access | Times Cited: 4
Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study
A. B. Hawthorne, Bradley Arms-Williams, Rebecca Cannings‐John, et al.
BMJ Open Gastroenterology (2024) Vol. 11, Iss. 1, pp. e001373-e001373
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top